{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:18:40Z","timestamp":1793031520096,"version":"4.5.0"},"reference-count":149,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T00:00:00Z","timestamp":1423785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["File No. 2011674067"],"award-info":[{"award-number":["File No. 2011674067"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IUAP","award":["BELVIR p7\/45"],"award-info":[{"award-number":["BELVIR p7\/45"]}]},{"name":"Mid-Career Researcher KHK","award":["2010-0029242"],"award-info":[{"award-number":["2010-0029242"]}]},{"name":"TEPIK"},{"name":"BK21"},{"DOI":"10.13039\/501100003130","name":"FWO","doi-asserted-by":"publisher","award":["3G052412N"],"award-info":[{"award-number":["3G052412N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>The successful isolation of a human influenza virus in 1933 was soon followed by the first attempts to develop an influenza vaccine. Nowadays, vaccination is still the most effective method to prevent human influenza disease. However, licensed influenza vaccines offer protection against antigenically matching viruses, and the composition of these vaccines needs to be updated nearly every year. Vaccines that target conserved epitopes of influenza viruses would in principle not require such updating and would probably have a considerable positive impact on global human health in case of a pandemic outbreak. The extracellular domain of Matrix 2 (M2e) protein is an evolutionarily conserved region in influenza A viruses and a promising epitope for designing a universal influenza vaccine. Here we review the seminal and recent studies that focused on M2e as a vaccine antigen. We address the mechanism of action and the clinical development of M2e-vaccines. Finally, we try to foresee how M2e-based vaccines could be implemented clinically in the future.<\/jats:p>","DOI":"10.3390\/vaccines3010105","type":"journal-article","created":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T10:40:07Z","timestamp":1423824007000},"page":"105-136","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":157,"title":["M2e-Based Universal Influenza A Vaccines"],"prefix":"10.3390","volume":"3","author":[{"given":"Lei","family":"Deng","sequence":"first","affiliation":[{"name":"Inflammation Research Center, VIB, Technologiepark 927, B-9052 Ghent, Belgium"},{"name":"Department for Biomedical Molecular Biology, Ghent University, Technologiepark 927,  B-9052 Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki","family":"Cho","sequence":"additional","affiliation":[{"name":"Inflammation Research Center, VIB, Technologiepark 927, B-9052 Ghent, Belgium"},{"name":"Department for Biomedical Molecular Biology, Ghent University, Technologiepark 927,  B-9052 Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Fiers","sequence":"additional","affiliation":[{"name":"Inflammation Research Center, VIB, Technologiepark 927, B-9052 Ghent, Belgium"},{"name":"Department for Biomedical Molecular Biology, Ghent University, Technologiepark 927,  B-9052 Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3861-6965","authenticated-orcid":false,"given":"Xavier","family":"Saelens","sequence":"additional","affiliation":[{"name":"Inflammation Research Center, VIB, Technologiepark 927, B-9052 Ghent, Belgium"},{"name":"Department for Biomedical Molecular Biology, Ghent University, Technologiepark 927,  B-9052 Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,2,13]]},"reference":[{"key":"ref_1","unstructured":"CDC (2010). Estimates of deaths associated with seasonal influenza\u2014United States, 1976\u20132007, MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archinte.1982.00340140087016","article-title":"Pneumonia and influenza deaths during epidemics: Implications for prevention","volume":"142","author":"Barker","year":"1982","journal-title":"Arch. Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0140-6736(11)61051-9","article-title":"Global burden of respiratory infections due to seasonal influenza in young children: A systematic review and meta-analysis","volume":"378","author":"Nair","year":"2011","journal-title":"Lancet"},{"key":"ref_4","first-page":"4","article-title":"The geography and mortality of the 1918 influenza pandemic","volume":"65","author":"Patterson","year":"1991","journal-title":"Bull. Hist. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1353\/bhm.2002.0022","article-title":"Updating the accounts: Global mortality of the 1918\u20131920 \u201cSpanish\u201d influenza pandemic","volume":"76","author":"Johnson","year":"2002","journal-title":"Bull. Hist. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.2105\/AJPH.87.12.1944","article-title":"The impact of influenza epidemics on mortality: Introducing a severity index","volume":"87","author":"Simonsen","year":"1997","journal-title":"Am. J. Public Health"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","article-title":"Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: A modelling study","volume":"12","author":"Dawood","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"ref_8","first-page":"e004189","article-title":"Calculating the burden of disease of avian-origin H7N9 infections in China","volume":"4","author":"Qi","year":"2014","journal-title":"Br. Med. J. Open"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/mr.56.1.152-179.1992","article-title":"Evolution and ecology of influenza A viruses","volume":"56","author":"Webster","year":"1992","journal-title":"Microbiol. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e1003657","DOI":"10.1371\/journal.ppat.1003657","article-title":"New world bats harbor diverse influenza A viruses","volume":"9","author":"Tong","year":"2013","journal-title":"PLOS Pathog."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1128\/JVI.02205-08","article-title":"Proteolytic activation of the 1918 influenza virus hemagglutinin","volume":"83","author":"Chaipan","year":"2009","journal-title":"J. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1073\/pnas.0308001101","article-title":"Human and avian influenza viruses target different cell types in cultures of human airway epithelium","volume":"101","author":"Matrosovich","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e4857","DOI":"10.1371\/journal.pone.0004857","article-title":"Host genetic background strongly influences the response to influenza a virus infections","volume":"4","author":"Srivastava","year":"2009","journal-title":"PLOS ONE"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/jmv.21218","article-title":"Study of influenza C virus infection in France","volume":"80","author":"Gouarin","year":"2008","journal-title":"J. Med. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/jmv.23756","article-title":"Influenza C virus infection in military recruits\u2014Symptoms and clinical manifestation","volume":"86","author":"Kauppila","year":"2014","journal-title":"J. Med. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1086\/502973","article-title":"Clinical features of influenza C virus infection in children","volume":"193","author":"Matsuzaki","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1023\/A:1007327505862","article-title":"Cold-adapted live attenuated influenza vaccines developed in Russia: Can they contribute to meeting the needs for influenza control in other countries?","volume":"13","author":"Kendal","year":"1997","journal-title":"Eur. J. Epidemiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.virol.2011.01.004","article-title":"Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A\/Leningrad\/134\/17\/57 (H2N2)","volume":"412","author":"Chen","year":"2011","journal-title":"Virology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1128\/CVI.00544-13","article-title":"Genetic and antigenic typing of seasonal influenza virus breakthrough cases from a 2008\u20132009 vaccine efficacy trial","volume":"21","author":"Durviaux","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e74064","DOI":"10.1371\/journal.pone.0074064","article-title":"Virological Surveillance of Influenza Viruses during the 2008\u201309, 2009\u201310 and 2010\u201311 Seasons in Tunisia","volume":"8","author":"Pozo","year":"2013","journal-title":"PLOS ONE"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Heikkinen, T., Ikonen, N., and Ziegler, T. (2014). Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999\u20132012. Clin. Infect. Dis.","DOI":"10.1093\/cid\/ciu664"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s40265-013-0114-3","article-title":"Inactivated quadrivalent split-virus seasonal influenza vaccine (Fluarix(R) quadrivalent): A review of its use in the prevention of disease caused by influenza A and B","volume":"73","author":"McKeage","year":"2013","journal-title":"Drugs"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/INF.0000000000000254","article-title":"Safety and immunogenicity of an inactivated quadrivalent influenza vaccine in children 6 months through 8 years of age","volume":"33","author":"Greenberg","year":"2014","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1126\/science.1186430","article-title":"Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus","volume":"328","author":"Xu","year":"2010","journal-title":"Science"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.coi.2014.02.005","article-title":"Eliciting broadly protective antibody responses against influenza","volume":"28","author":"Kirchenbaum","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virusres.2014.03.015","article-title":"Molecular mechanisms enhancing the proteome of influenza A viruses: An overview of recently discovered proteins","volume":"185","author":"Vasin","year":"2014","journal-title":"Virus Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0042-6822(81)90317-2","article-title":"Identification of a second protein (M2) encoded by RNA segment 7 of influenza virus","volume":"112","author":"Lamb","year":"1981","journal-title":"Virology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1073\/pnas.78.7.4170","article-title":"Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: Colinear and interrupted mRNAs code for overlapping proteins","volume":"78","author":"Lamb","year":"1981","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"15409","DOI":"10.1073\/pnas.1009997107","article-title":"Proton and cation transport activity of the M2 proton channel from influenza A virus","volume":"107","author":"Leiding","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"13029","DOI":"10.1128\/JVI.01430-14","article-title":"Stepwise priming by acidic pH and a high K+ concentration is required for efficient uncoating of influenza A virus cores after penetration","volume":"88","author":"Stauffer","year":"2014","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0092-8674(92)90219-3","article-title":"Unpacking the incoming influenza virus","volume":"69","author":"Helenius","year":"1992","journal-title":"Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1016\/j.vaccine.2012.03.021","article-title":"Immunization with high epitope density of M2e derived from 2009 pandemic H1N1 elicits protective immunity in mice","volume":"30","author":"Zhou","year":"2012","journal-title":"Vaccine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1099\/0022-1317-74-1-143","article-title":"Antibody response to the M2 protein of influenza A virus expressed in insect cells","volume":"74","author":"Black","year":"1993","journal-title":"J. Gen. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e1002998","DOI":"10.1371\/journal.ppat.1002998","article-title":"Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain","volume":"8","author":"Wise","year":"2012","journal-title":"PLOS Pathog."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nature06528","article-title":"Structural basis for the function and inhibition of an influenza virus proton channel","volume":"451","author":"Stouffer","year":"2008","journal-title":"Nature"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1073\/pnas.0811720106","article-title":"Molecular dynamics calculations suggest a conduction mechanism for the M2 proton channel from influenza A virus","volume":"106","author":"Khurana","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1126\/science.1191750","article-title":"Insight into the mechanism of the influenza A proton channel from a structure in a lipid bilayer","volume":"330","author":"Sharma","year":"2010","journal-title":"Science"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7379","DOI":"10.1073\/pnas.0902548106","article-title":"Mechanism of drug inhibition and drug resistance of influenza A M2 channel","volume":"106","author":"Pielak","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature06531","article-title":"Structure and mechanism of the M2 proton channel of influenza A virus","volume":"451","author":"Schnell","year":"2008","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.str.2011.09.003","article-title":"Structural investigation of rimantadine inhibition of the AM2-BM2 chimera channel of influenza viruses","volume":"19","author":"Pielak","year":"2011","journal-title":"Structure"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1128\/JVI.79.6.3595-3605.2005","article-title":"The influenza A virus M2 cytoplasmic tail is required for infectious virus production and efficient genome packaging","volume":"79","author":"McCown","year":"2005","journal-title":"J. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8178","DOI":"10.1128\/JVI.00627-06","article-title":"Distinct domains of the influenza a virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production","volume":"80","author":"McCown","year":"2006","journal-title":"J. Virol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1128\/JVI.00119-10","article-title":"Influenza virus m2 ion channel protein is necessary for filamentous virion formation","volume":"84","author":"Rossman","year":"2010","journal-title":"J. Virol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.cell.2010.08.029","article-title":"Influenza virus M2 protein mediates ESCRT-independent membrane scission","volume":"142","author":"Rossman","year":"2010","journal-title":"Cell"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0042-6822(92)90730-D","article-title":"Evidence that the amantadine-induced, M2-mediated conversion of influenza A virus hemagglutinin to the low pH conformation occurs in an acidic trans Golgi compartment","volume":"188","author":"Ciampor","year":"1992","journal-title":"Virology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1099\/vir.0.80358-0","article-title":"Influence of residue 44 on the activity of the M2 proton channel of influenza A virus","volume":"86","author":"Betakova","year":"2005","journal-title":"J. Gen. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0042-6822(92)91187-Y","article-title":"Maturation of influenza A virus hemagglutinin\u2014Estimates of the pH encountered during transport and its regulation by the M2 protein","volume":"190","author":"Grambas","year":"1992","journal-title":"Virology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ni.1861","article-title":"Influenza virus activates inflammasomes via its intracellular M2 ion channel","volume":"11","author":"Ichinohe","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.chom.2009.05.016","article-title":"Autophagy, immunity, and microbial adaptations","volume":"5","author":"Deretic","year":"2009","journal-title":"Cell Host Microbe"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.chom.2009.09.005","article-title":"Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes","volume":"6","author":"Gannage","year":"2009","journal-title":"Cell Host Microbe"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.chom.2014.01.006","article-title":"A LC3-interacting motif in the influenza A virus M2 protein is required to subvert autophagy and maintain virion stability","volume":"15","author":"Beale","year":"2014","journal-title":"Cell Host Microbe"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Feng, J., Zhang, M., Mozdzanowska, K., Zharikova, D., Hoff, H., Wunner, W., Couch, R.B., and Gerhard, W. (2006). Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2. Virol. J.","DOI":"10.1186\/1743-422X-3-102"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Hutchinson, E.C., Charles, P.D., Hester, S.S., Thomas, B., Trudgian, D., Martinez-Alonso, M., and Fodor, E. (2014). Conserved and host-specific features of influenza virion architecture. Nat. Commun.","DOI":"10.1038\/ncomms5816"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1099\/0022-1317-82-11-2697","article-title":"Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection","volume":"82","author":"Heinen","year":"2001","journal-title":"J. Gen. Virol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e28445","DOI":"10.1371\/journal.pone.0028445","article-title":"Vaccination with M2e-based multiple antigenic peptides: Characterization of the B cell response and protection efficacy in inbred and outbred mice","volume":"6","author":"Wolf","year":"2011","journal-title":"PLOS ONE"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e56801","DOI":"10.1371\/journal.pone.0056801","article-title":"Recombinant M2e protein-based ELISA: A novel and inexpensive approach for differentiating avian influenza infected chickens from vaccinated ones","volume":"8","author":"Hemmatzadeh","year":"2013","journal-title":"PLOS ONE"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1637\/7589-040206R.1","article-title":"Development of an M2e-specific enzyme-linked immunosorbent assay for differentiating infected from vaccinated animals","volume":"51","author":"Lambrecht","year":"2007","journal-title":"Avian Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/infdis\/jit811","article-title":"Serum antibody response to matrix protein 2 following natural infection with 2009 pandemic influenza A(H1N1) virus in humans","volume":"209","author":"Zhong","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"7578","DOI":"10.4049\/jimmunol.162.12.7578","article-title":"Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species","volume":"162","author":"Jameson","year":"1999","journal-title":"J. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"8682","DOI":"10.1128\/JVI.72.11.8682-8689.1998","article-title":"Human cytotoxic T-lymphocyte repertoire to influenza A viruses","volume":"72","author":"Jameson","year":"1998","journal-title":"J. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0198-8859(00)00105-1","article-title":"Human memory CTL response specific for influenza A virus is broad and multispecific","volume":"61","author":"Gianfrani","year":"2000","journal-title":"Hum. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jim.2003.07.004","article-title":"T-cell hybridomas from HLA-transgenic mice as tools for analysis of human antigen processing","volume":"281","author":"Canaday","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.vaccine.2007.12.027","article-title":"CTA1-M2e-DD: A novel mucosal adjuvant targeted influenza vaccine","volume":"26","author":"Eliasson","year":"2008","journal-title":"Vaccine"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/icb.2010.15","article-title":"A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody","volume":"88","author":"Pejoski","year":"2010","journal-title":"Immunol. Cell Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1099\/vir.0.027086-0","article-title":"Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective","volume":"92","author":"Ysenbaert","year":"2011","journal-title":"J. Gen. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1016\/j.vaccine.2010.06.069","article-title":"Genetic control of immune responses to influenza A matrix 2 protein (M2)","volume":"28","author":"Misplon","year":"2010","journal-title":"Vaccine"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1016\/j.vaccine.2014.06.040","article-title":"AS04-adjuvanted virus-like particles containing multiple M2 extracellular domains of influenza virus confer improved protection","volume":"32","author":"Lee","year":"2014","journal-title":"Vaccine"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/mt.2012.246","article-title":"Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus","volume":"21","author":"Kim","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e77084","DOI":"10.1371\/journal.pone.0077084","article-title":"A novel M2e based flu vaccine formulation for dogs","volume":"8","author":"Leclerc","year":"2013","journal-title":"PLOS ONE"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.2174\/13816128113199990337","article-title":"Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by Tobacco mosaic virus-based vectors","volume":"19","author":"Petukhova","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"73","DOI":"10.32607\/20758251-2011-3-4-73-82","article-title":"New viral vector for superproduction of epitopes of vaccine proteins in plants","volume":"3","author":"Tyulkina","year":"2011","journal-title":"Acta Naturae"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1016\/j.vaccine.2008.04.052","article-title":"Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform","volume":"26","author":"Denis","year":"2008","journal-title":"Vaccine"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Matic, S., Rinaldi, R., Masenga, V., and Noris, E. (2011). Efficient production of chimeric human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants. BMC Biotechnol.","DOI":"10.1186\/1472-6750-11-106"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1016\/j.vaccine.2010.07.083","article-title":"Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype","volume":"28","author":"Ameiss","year":"2010","journal-title":"Vaccine"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e45765","DOI":"10.1371\/journal.pone.0045765","article-title":"Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge","volume":"7","author":"Hashemi","year":"2012","journal-title":"PLOS ONE"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/eji.200636959","article-title":"Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: Implications for vaccine design","volume":"38","author":"Bessa","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"11382","DOI":"10.1074\/jbc.M800650200","article-title":"An influenza A vaccine based on tetrameric ectodomain of matrix protein 2","volume":"283","author":"Martens","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e46395","DOI":"10.1371\/journal.pone.0046395","article-title":"Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein","volume":"7","author":"Andersson","year":"2012","journal-title":"PLOS ONE"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/S0264-410X(03)00040-9","article-title":"Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2","volume":"21","author":"Mozdzanowska","year":"2003","journal-title":"Vaccine"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Mozdzanowska, K., Zharikova, D., Cudic, M., Otvos, L., and Gerhard, W. (2007). Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse. Virol. J.","DOI":"10.1186\/1743-422X-4-118"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Zhao, G., Lin, Y., Du, L., Guan, J., Sun, S., Sui, H., Kou, Z., Chan, C.C., Guo, Y., and Jiang, S. (2010). An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses. Virol. J.","DOI":"10.1186\/1743-422X-7-9"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Zhao, G., Sun, S., Du, L., Xiao, W., Ru, Z., Kou, Z., Guo, Y., Yu, H., Jiang, S., and Lone, Y. (2010). An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus. Virol. J.","DOI":"10.1186\/1743-422X-7-151"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0928-8244(03)00009-9","article-title":"N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication","volume":"35","author":"Liu","year":"2003","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.vaccine.2004.02.021","article-title":"Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys","volume":"22","author":"Fan","year":"2004","journal-title":"Vaccine"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.vaccine.2008.12.034","article-title":"Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys","volume":"27","author":"Fu","year":"2009","journal-title":"Vaccine"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1016\/j.vaccine.2011.05.041","article-title":"Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults","volume":"29","author":"Turley","year":"2011","journal-title":"Vaccine"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.vaccine.2007.10.062","article-title":"Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin","volume":"26","author":"Huleatt","year":"2008","journal-title":"Vaccine"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e14442","DOI":"10.1371\/journal.pone.0014442","article-title":"Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin","volume":"5","author":"Talbot","year":"2010","journal-title":"PLOS ONE"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.vaccine.2012.11.072","article-title":"Tandem repeats of the extracellular domain of Matrix 2 influenza protein exposed in Brucella lumazine synthase decameric carrier molecule induce protection in mice","volume":"31","author":"Alvarez","year":"2013","journal-title":"Vaccine"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/JVI.01141-13","article-title":"A novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2","volume":"88","author":"Herve","year":"2014","journal-title":"J. Virol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1586\/erv.09.77","article-title":"DNA vaccines in veterinary use","volume":"8","author":"Redding","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/vim.2011.0093","article-title":"DNA-vaccine platform development against H1N1 subtype of swine influenza A viruses","volume":"25","author":"Wei","year":"2012","journal-title":"Viral Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Wang, B., Yu, H., Yang, F.R., Huang, M., Ma, J.H., and Tong, G.Z. (2012). Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin. Virol. J.","DOI":"10.1186\/1743-422X-9-127"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1016\/j.vaccine.2011.05.062","article-title":"Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e","volume":"29","author":"Park","year":"2011","journal-title":"Vaccine"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1086\/588431","article-title":"Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A\/Vietnam\/1203\/04 (H5N1) influenza virus","volume":"197","author":"Lalor","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1016\/S0264-410X(01)00078-0","article-title":"Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene","volume":"19","author":"Okuda","year":"2001","journal-title":"Vaccine"},{"key":"ref_98","first-page":"437","article-title":"Viroporins from RNA viruses induce caspase-dependent apoptosis","volume":"10","author":"Madan","year":"2008","journal-title":"Cell Microbiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/mt.2012.248","article-title":"Hexon-modified recombinant E1-deleted adenovirus vectors as dual specificity vaccine carriers for influenza virus","volume":"21","author":"Zhou","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"9693","DOI":"10.1128\/JVI.00823-14","article-title":"Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice","volume":"88","author":"Kim","year":"2014","journal-title":"J. Virol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3382\/ps.2009-00251","article-title":"Vaccination of chickens with recombinant Salmonella expressing M2e and CD154 epitopes increases protection and decreases viral shedding after low pathogenic avian influenza challenge","volume":"88","author":"Layton","year":"2009","journal-title":"Poult. Sci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e88340","DOI":"10.1371\/journal.pone.0088340","article-title":"MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses","volume":"9","author":"Hessel","year":"2014","journal-title":"PLOS ONE"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1128\/jvi.67.5.2552-2558.1993","article-title":"A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains","volume":"67","author":"Okuno","year":"1993","journal-title":"J. Virol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1128\/iai.9.1.101-105.1974","article-title":"Simian model for the evaluation of immunity to influenza","volume":"9","author":"Berendt","year":"1974","journal-title":"Infect. Immun."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/erv.09.148","article-title":"Animal models for the preclinical evaluation of candidate influenza vaccines","volume":"9","author":"Bodewes","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2353\/ajpath.2007.070248","article-title":"Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals","volume":"171","author":"Munster","year":"2007","journal-title":"Am. J. Pathol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/laban1004-50","article-title":"The ferret: An animal model to study influenza virus","volume":"33","author":"Maher","year":"2004","journal-title":"Lab. Anim. (NY)"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.1128\/JVI.72.9.7367-7373.1998","article-title":"Molecular basis for the generation in pigs of influenza A viruses with pandemic potential","volume":"72","author":"Ito","year":"1998","journal-title":"J. Virol."},{"key":"ref_110","first-page":"158","article-title":"The pig as a mixing vessel for influenza viruses: Human and veterinary implications","volume":"3","author":"Ma","year":"2008","journal-title":"J. Mol. Genet. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1099\/0022-1317-83-8-1851","article-title":"Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus","volume":"83","author":"Heinen","year":"2002","journal-title":"J. Gen. Virol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Reese, K.A., Lupfer, C., Johnson, R.C., Mitev, G.M., Mullen, V.M., Geller, B.L., and Pastey, M. (2013). A novel lactococcal vaccine expressing a peptide from the M2 antigen of H5N2 highly pathogenic avian Influenza A virus prolongs survival of vaccinated chickens. Vet. Med. Int.","DOI":"10.1155\/2013\/316926"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000319440","article-title":"Vaccination with different M2e epitope densities confers partial protection against H5N1 influenza A virus challenge in chickens","volume":"54","author":"Zhang","year":"2011","journal-title":"Intervirology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/jvi.62.8.2762-2772.1988","article-title":"Influenza A virus M2 protein: Monoclonal antibody restriction of virus growth and detection of M2 in virions","volume":"62","author":"Zebedee","year":"1988","journal-title":"J. Virol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1128\/jvi.64.3.1375-1377.1990","article-title":"Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice","volume":"64","author":"Treanor","year":"1990","journal-title":"J. Virol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.1128\/JVI.79.11.6644-6654.2005","article-title":"Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2","volume":"79","author":"Zharikova","year":"2005","journal-title":"J. Virol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.imlet.2004.03.003","article-title":"Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge","volume":"93","author":"Liu","year":"2004","journal-title":"Immunol. Lett."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1073\/pnas.0911806107","article-title":"Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses","volume":"107","author":"Grandea","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.virol.2008.11.035","article-title":"Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus","volume":"385","author":"Fu","year":"2009","journal-title":"Virology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1016\/j.vaccine.2006.04.008","article-title":"Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines","volume":"24","author":"Ernst","year":"2006","journal-title":"Vaccine"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3201\/eid1303.061125","article-title":"Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1","volume":"13","author":"Tompkins","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"Influenza A vaccine based on the extracellular domain of M2: Weak protection mediated via antibody-dependent NK cell activity","volume":"172","author":"Jegerlehner","year":"2004","journal-title":"J. Immunol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"Descamps","year":"2011","journal-title":"J. Immunol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2008.06.002","article-title":"Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein","volume":"80","author":"Wang","year":"2008","journal-title":"Antiviral Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"8868","DOI":"10.1016\/j.vaccine.2007.09.056","article-title":"Characterization of immunity induced by M2e of influenza virus","volume":"25","author":"Wu","year":"2007","journal-title":"Vaccine"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1128\/JVI.76.1.432-435.2002","article-title":"Increased efficacy of the immunoglobulin G2a subclass in antibody-mediated protection against lactate dehydrogenase-elevating virus-induced polioencephalomyelitis revealed with switch mutants","volume":"76","author":"Coutelier","year":"2002","journal-title":"J. Virol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.vaccine.2005.08.061","article-title":"The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection","volume":"24","author":"Ramne","year":"2006","journal-title":"Vaccine"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nri3582","article-title":"The function of Fcgamma receptors in dendritic cells and macrophages","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.4049\/jimmunol.0901699","article-title":"Chicken IgY binds its receptor at the CH3\/CH4 interface similarly as the human IgA: Fc alpha RI interaction","volume":"183","author":"Purzel","year":"2009","journal-title":"J. Immunol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"11718","DOI":"10.1073\/pnas.0702011104","article-title":"The chicken leukocyte receptor complex encodes a primordial, activating, high-affinity IgY Fc receptor","volume":"104","author":"Viertlboeck","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.4049\/jimmunol.153.12.5549","article-title":"One gene encodes the heavy chains for three different forms of IgY in the duck","volume":"153","author":"Magor","year":"1994","journal-title":"J. Immunol."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Ramos, E.L., Mitcham, J.L., Koller, T.D., Bonavia, A., Usner, D.W., Balaratnam, G., Fredlund, P., and Swiderek, K.M. (2014). Efficacy and safety of treatment with an anti-M2e monoclonal antibody in experimental human influenza. J. Infect. Dis.","DOI":"10.1093\/infdis\/jiu539"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.antiviral.2014.08.016","article-title":"Evaluation of a fully human monoclonal antibody against multiple influenza A viral strains in mice and a pandemic H1N1 strain in nonhuman primates","volume":"111C","author":"Song","year":"2014","journal-title":"Antiviral Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/mi.2012.69","article-title":"Natural and long-lasting cellular immune responses against influenza in the M2e-immune host","volume":"6","author":"Schotsaert","year":"2013","journal-title":"Mucosal. Immunol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1473-3099(09)70263-4","article-title":"Yearly influenza vaccinations: A double-edged sword?","volume":"9","author":"Bodewes","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"ref_136","unstructured":"CDC (2013). Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2013\u20132014, MMWR Recomm. Rep."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e5538","DOI":"10.1371\/journal.pone.0005538","article-title":"Vaccination against human influenza A\/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A\/H5N1 virus","volume":"4","author":"Bodewes","year":"2009","journal-title":"PLOS ONE"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1128\/JVI.02371-10","article-title":"Vaccination against seasonal influenza A\/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A\/H5N1 virus infection in ferrets","volume":"85","author":"Bodewes","year":"2011","journal-title":"J. Virol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1099\/vir.0.020784-0","article-title":"Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A\/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice","volume":"91","author":"Bodewes","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"11995","DOI":"10.1128\/JVI.05213-11","article-title":"Annual vaccination against influenza virus hampers development of virus-specific CD8+ T cell immunity in children","volume":"85","author":"Bodewes","year":"2011","journal-title":"J. Virol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.vaccine.2004.05.028","article-title":"High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity","volume":"23","author":"Liu","year":"2004","journal-title":"Vaccine"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1016\/j.vaccine.2006.05.082","article-title":"Improved design and intranasal delivery of an M2e-based human influenza A vaccine","volume":"24","author":"Fiers","year":"2006","journal-title":"Vaccine"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/eji.200425749","article-title":"High epitope density in a single protein molecule significantly enhances antigenicity as well as immunogenicity: A novel strategy for modern vaccine development and a preliminary investigation about B cell discrimination of monomeric proteins","volume":"35","author":"Liu","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.virol.2005.04.004","article-title":"Universal influenza A vaccine: Optimization of M2-based constructs","volume":"337","author":"Birkett","year":"2005","journal-title":"Virology"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1086\/386330","article-title":"Intranasal influenza vaccine in a working population","volume":"38","author":"Sendi","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_146","unstructured":"Dynavax reports new phase 1a and phase 1b data for universal flu vaccine candidate. Available online: http:\/\/investors.dynavax.com\/releasedetail.cfm?ReleaseID=551606&refdoi=10.1186\/1471\u20132458\u201313-s3-s14."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1016\/j.vaccine.2009.07.007","article-title":"M2e-based universal influenza A vaccine","volume":"27","author":"Fiers","year":"2009","journal-title":"Vaccine"},{"key":"ref_148","unstructured":"Safety study of recombinant M2e influenza-A vaccine in healthy adults (FLU-A), Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00819013?term=Acam-flu-A&rank=1."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.vaccine.2010.01.029","article-title":"Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin","volume":"28","author":"Smith","year":"2010","journal-title":"Vaccine"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/3\/1\/105\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:42:41Z","timestamp":1760215361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/3\/1\/105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,13]]},"references-count":149,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,3]]}},"alternative-id":["vaccines3010105"],"URL":"https:\/\/doi.org\/10.3390\/vaccines3010105","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,13]]}}}